Abstract

Excitatory agonists can induce significant smooth muscle contraction under constant free Ca(2+) through a mechanism called Ca(2+) sensitization. Considerable evidence suggests that free arachidonic acid plays an important role in mediating agonist-induced Ca(2+)-sensitization; however, the molecular mechanisms responsible for maintaining and regulating free arachidonic acid level are not completely understood. In the current study, we demonstrated that Ca(2+)-independent phospholipase A(2) (iPLA(2)) is expressed in vascular smooth muscle tissues. Inhibition of the endogenous iPLA(2) activity by bromoenol lactone (BEL) decreases basal free arachidonic acid levels and reduces the final free arachidonic acid level after phenylephrine stimulation, without significant effect on the net increase in free arachidonic acid stimulated by phenylephrine. Importantly, BEL treatment diminishes agonist-induced Ca(2+) sensitization of contraction from 49 +/- 3.6 to 12 +/- 1.0% (p < 0.01). In contrast, BEL does not affect agonist-induced diacylglycerol production or contraction induced by Ca(2+), phorbol 12,13-dibutyrate (a protein kinase C activator), or exogenous arachidonic acid. Further, we demonstrate that adenovirus-mediated overexpression of exogenous iPLA(2) in mouse portal vein tissue significantly potentiates serotonin-induced contraction. Our data provide the first evidence that iPLA(2) is required for maintaining basal free arachidonic acid levels and thus is essential for agonist-induced Ca(2+)-sensitization of contraction in vascular smooth muscle.

Highlights

  • Excitatory agonists can induce significant smooth muscle contraction under constant free Ca2؉ through a mechanism called Ca2؉ sensitization

  • We demonstrated that Ca2؉-independent phospholipase A2 is expressed in vascular smooth muscle tissues

  • Our results show that independent phospholipase A2 (iPLA2) is expressed in vascular smooth muscle tissue, and inhibition of the endogenous iPLA2 activity by bromoenol lactone (BEL) decreases basal free arachidonic acid levels and diminishes phenylephrine-induced Ca2ϩ sensitization of contraction

Read more

Summary

The abbreviations used are

GTP␥S, guanosine 5Ј-3-O-(thio)triphosphate; BEL, bromoenol lactone; DAG, diacylglycerol; PDBu, phorbol12,13-dibutyrate; PE, phenylephrine; PLA2, phospholipase A2; cPLA2, cytosol PLA2; iPLA2, Ca2ϩ-independent PLA2; sPLA2, secretory PLA2; PAP, phosphatidate phosphohydrolase; GFP, green fluorescent protein; DPPC, 1-palmitoyl-2-palmitoyl-L-3-phosphatidylcholine. It is clear that iPLA2 represents a diverse group of enzymes that have distinct and different sequences, molecular weights, subcellular localizations, and tissue distributions [30, 38] Consistent with these diversities, iPLA2 has been implicated in divergent cellular functions, including membrane phospholipid remodeling [39, 40], glucose-induced insulin secretion [33, 41], Fas-induced apoptosis [42, 43], phosphatidylcholine homeostasis [44, 45], cell proliferation (46 – 48), eicosanoid synthesis [49, 50], Ca2ϩ influx [51, 52], preadipocyte spreading [53], and membrane traffic [54]. We conclude that iPLA2 is required for agonist-induced Ca2ϩ sensitization of contraction in vascular smooth muscle

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call